Feedback / Questions
tegoprubart (AT-1501) - Eledon
https://www.globenewswire.com/news-release/2025/11/18/3190482/0/en/Eledon-Reports-Preliminary-Data-from-First-Six-Patients-with-Type-1-Diabetes-Treated-with-Tegoprubart-as-the-Core-Immunosuppressant-Following-Islet-Transplantation-in-Investigator-.html
Nov 18, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next